Variation in RARG increases susceptibility to doxorubicin-induced cardiotoxicity in patient specific induced pluripotent stem cell-derived cardiomyocytes

Doxorubicin is a potent anticancer drug used to treat a variety of cancer types. However, its use is limited by doxorubicin-induced cardiotoxicity (DIC). A missense variant in the RARG gene (S427L; rs2229774) has been implicated in susceptibility to DIC in a genome wide association study. The goal o...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Sci Rep
Главные авторы: Christidi, Effimia, Huang, Haojun, Shafaattalab, Sanam, Maillet, Agnes, Lin, Eric, Huang, Kate, Laksman, Zachary, Davis, Margot K., Tibbits, Glen F., Brunham, Liam R.
Формат: Artigo
Язык:Inglês
Опубликовано: Nature Publishing Group UK 2020
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7316788/
https://ncbi.nlm.nih.gov/pubmed/32587261
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-65979-x
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы